Signals that regulate the oncogenic fate of neural stem cells and progenitors

Experimental Neurology

Volumn 260, Issue , 2014, Pages 56-68

  Swartling, Fredrik J ^a   Bolin, Sara ^a   Phillips, Joanna J ^b   Persson, Anders I ^b,c  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain tumor; Glioma; Medulloblastoma; MiRNA; Neural stem cell; Progenitor; Reprogramming

Indexed keywords

MICRORNA;

ASTROCYTOMA; CARCINOGENESIS; CELL FATE; CHILDHOOD CANCER; EPENDYMOMA; FOREBRAIN; GENETICALLY ENGINEERED MOUSE STRAIN; GLIOBLASTOMA; GLIOMA; HUMAN; MEDULLOBLASTOMA; NEURAL STEM CELL; NEUROECTODERM TUMOR; NONHUMAN; OLIGODENDROGLIOMA; PILOCYTIC ASTROCYTOMA; REVIEW; RHOMBENCEPHALON; SIGNAL TRANSDUCTION; STEM CELL; TUMOR MICROENVIRONMENT; ANIMAL; BRAIN TUMOR; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSFORMATION; CYTOLOGY; GENETICS; PHYSIOLOGY; PROGENITOR; REPROGRAMMING;

BRAIN TUMOR; GLIOMA; MEDULLOBLASTOMA; MIRNA; NEURAL STEM CELL; PROGENITOR; REPROGRAMMING;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; NEURAL STEM CELLS; SIGNAL TRANSDUCTION; STEM CELLS;

EID: 84908381676     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2013.01.027     Document Type: Review

References (205)

1. Ables J.L., Breunig J.J., Eisch A.J., Rakic P. Not(ch) just development: Notch signalling in the adult brain. Nat. Rev. Neurosci. 2011, 12:269-283.
2. Abrajano J.J., Qureshi I.A., Gokhan S., Molero A.E., Zheng D., Bergman A., Mehler M.F. Corepressor for element-1-silencing transcription factor preferentially mediates gene networks underlying neural stem cell fate decisions. Proc. Natl. Acad. Sci. U. S. A. 2010, 107:16685-16690.
3. Alcantara Llaguno S., Chen J., Kwon C.H., Jackson E.L., Li Y., Burns D.K., Alvarez-Buylla A., Parada L.F. Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model. Cancer Cell 2009, 15:45-56.
4. Alva J.A., Lee G.E., Escobar E.E., Pyle A.D. Phosphatase and tensin homolog regulates the pluripotent state and lineage fate choice in human embryonic stem cells. Stem Cells 2011, 29:1952-1962.
5. Alvarez-Medina R., Cayuso J., Okubo T., Takada S., Marti E. Wnt canonical pathway restricts graded Shh/Gli patterning activity through the regulation of Gli3 expression. Development 2008, 135:237-247.
6. Aranha M.M., Santos D.M., Sola S., Steer C.J., Rodrigues C.M. miR-34a regulates mouse neural stem cell differentiation. PLoS One 2011, 6:e21396.
7. Bachoo R.M., Maher E.A., Ligon K.L., Sharpless N.E., Chan S.S., You M.J., Tang Y., DeFrances J., Stover E., Weissleder R., Rowitch D.H., Louis D.N., DePinho R.A. Epidermal growth factor receptor and Ink4a/Arf: convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis. Cancer Cell 2002, 1:269-277.
8. Ballas N., Grunseich C., Lu D.D., Speh J.C., Mandel G. REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 2005, 121:645-657.
9. Bao S., Wu Q., McLendon R.E., Hao Y., Shi Q., Hjelmeland A.B., Dewhirst M.W., Bigner D.D., Rich J.N. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006, 444:756-760.
10. Basak O., Giachino C., Fiorini E., Macdonald H.R., Taylor V. Neurogenic subventricular zone stem/progenitor cells are Notch1-dependent in their active but not quiescent state. J. Neurosci. 2012, 32:5654-5666.
11. Behdad A., Perry A. Central nervous system primitive neuroectodermal tumors: a clinicopathologic and genetic study of 33 cases. Brain Pathol. 2010, 20:441-450.
12. Ben-Porath I., Thomson M.W., Carey V.J., Ge R., Bell G.W., Regev A., Weinberg R.A. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat. Genet. 2008, 40:499-507.
13. Bettegowda C., Agrawal N., Jiao Y., Sausen M., Wood L.D., Hruban R.H., Rodriguez F.J., Cahill D.P., McLendon R., Riggins G., Velculescu V.E., Oba-Shinjo S.M., Marie S.K., Vogelstein B., Bigner D., Yan H., Papadopoulos N., Kinzler K.W. Mutations in CIC and FUBP1 contribute to human oligodendroglioma. Science 2011, 333:1453-1455.
14. Bhat K.P., Salazar K.L., Balasubramaniyan V., Wani K., Heathcock L., Hollingsworth F., James J.D., Gumin J., Diefes K.L., Kim S.H., Turski A., Azodi Y., Yang Y., Doucette T., Colman H., Sulman E.P., Lang F.F., Rao G., Copray S., Vaillant B.D., Aldape K.D. The transcriptional coactivator TAZ regulates mesenchymal differentiation in malignant glioma. Genes Dev. 2011, 25:2594-2609.
15. Carro M.S., Lim W.K., Alvarez M.J., Bollo R.J., Zhao X., Snyder E.Y., Sulman E.P., Anne S.L., Doetsch F., Colman H., Lasorella A., Aldape K., Califano A., Iavarone A. The transcriptional network for mesenchymal transformation of brain tumours. Nature 2010, 463:318-325.
16. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65:6029-6033.
17. Chapouton P., Skupien P., Hesl B., Coolen M., Moore J.C., Madelaine R., Kremmer E., Faus-Kessler T., Blader P., Lawson N.D., Bally-Cuif L. Notch activity levels control the balance between quiescence and recruitment of adult neural stem cells. J. Neurosci. 2010, 30:7961-7974.
18. Chen J., Li Y., Yu T.S., McKay R.M., Burns D.K., Kernie S.G., Parada L.F. A restricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
19. Cheng L.C., Pastrana E., Tavazoie M., Doetsch F. miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche. Nat. Neurosci. 2009, 12:399-408.
20. Chenn A., Walsh C.A. Regulation of cerebral cortical size by control of cell cycle exit in neural precursors. Science 2002, 297:365-369.
21. Cho Y.J., Tsherniak A., Tamayo P., Santagata S., Ligon A., Greulich H., Berhoukim R., Amani V., Goumnerova L., Eberhart C.G., Lau C.C., Olson J.M., Gilbertson R.J., Gajjar A., Delattre O., Kool M., Ligon K., Meyerson M., Mesirov J.P., Pomeroy S.L. Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome. J. Clin. Oncol. 2011, 29:1424-1430.
22. Choi Y.J., Lin C.P., Ho J.J., He X., Okada N., Bu P., Zhong Y., Kim S.Y., Bennett M.J., Chen C., Ozturk A., Hicks G.G., Hannon G.J., He L. miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat. Cell Biol. 2011, 13:1353-1360.
23. Chojnacki A., Mak G., Weiss S. PDGFRalpha expression distinguishes GFAP-expressing neural stem cells from PDGF-responsive neural precursors in the adult periventricular area. J. Neurosci. 2011, 31:9503-9512.
24. Clement V., Sanchez P., de Tribolet N., Radovanovic I., Ruiz i Altaba A. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr. Biol. 2007, 17:165-172.
25. Conti L., Crisafulli L., Caldera V., Tortoreto M., Brilli E., Conforti P., Zunino F., Magrassi L., Schiffer D., Cattaneo E. REST controls self-renewal and tumorigenic competence of human glioblastoma cells. PLoS One 2012, 7:e38486.
26. Cooper L.A., Gutman D.A., Long Q., Johnson B.A., Cholleti S.R., Kurc T., Saltz J.H., Brat D.J., Moreno C.S. The proneural molecular signature is enriched in oligodendrogliomas and predicts improved survival among diffuse gliomas. PLoS One 2010, 5:e12548.
27. Cooper L.A., Gutman D.A., Chisolm C., Appin C., Kong J., Rong Y., Kurc T., Van Meir E.G., Saltz J.H., Moreno C.S., Brat D.J. The tumor microenvironment strongly impacts master transcriptional regulators and gene expression class of glioblastoma. Am. J. Pathol. 2012, 180:2108-2119.
28. Curtis M.A., Kam M., Nannmark U., Anderson M.F., Axell M.Z., Wikkelso C., Holtas S., van Roon-Mom W.M., Bjork-Eriksson T., Nordborg C., Frisen J., Dragunow M., Faull R.L., Eriksson P.S. Human neuroblasts migrate to the olfactory bulb via a lateral ventricular extension. Science 2007, 315:1243-1249.
29. Dahmane N., Ruiz i Altaba A. Sonic hedgehog regulates the growth and patterning of the cerebellum. Development 1999, 126:3089-3100.
30. Dawson M.R., Polito A., Levine J.M., Reynolds R. NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Mol. Cell. Neurosci. 2003, 24:476-488.
31. de Antonellis P., Medaglia C., Cusanelli E., Andolfo I., Liguori L., De Vita G., Carotenuto M., Bello A., Formiggini F., Galeone A., De Rosa G., Virgilio A., Scognamiglio I., Sciro M., Basso G., Schulte J.H., Cinalli G., Iolascon A., Zollo M. MiR-34a targeting of Notch ligand delta-like 1 impairs CD15+/CD133+ tumor-propagating cells and supports neural differentiation in medulloblastoma. PLoS One 2011, 6:e24584.
32. De Bacco F., Casanova E., Medico E., Pellegatta S., Orzan F., Albano R., Luraghi P., Reato G., D'Ambrosio A., Porrati P., Patane M., Maderna E., Pollo B., Comoglio P.M., Finocchiaro G., Boccaccio C. The MET oncogene is a functional marker of a glioblastoma stem cell subtype. Cancer Res. 2012, 72:4537-4550.
33. Easwaran H., Johnstone S.E., Van Neste L., Ohm J., Mosbruger T., Wang Q., Aryee M.J., Joyce P., Ahuja N., Weisenberger D., Collisson E., Zhu J., Yegnasubramanian S., Matsui W., Baylin S.B. A DNA hypermethylation module for the stem/progenitor cell signature of cancer. Genome Res. 2012, 22:837-849.
34. Eberhart C.G. Three down and one to go: modeling medulloblastoma subgroups. Cancer Cell 2012, 21:137-138.
35. Ellison D.W., Dalton J., Kocak M., Nicholson S.L., Fraga C., Neale G., Kenney A.M., Brat D.J., Perry A., Yong W.H., Taylor R.E., Bailey S., Clifford S.C., Gilbertson R.J. Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups. Acta Neuropathol. 2011, 121:381-396.
36. Engler J.R., Robinson A.E., Smirnov I., Hodgson J.G., Berger M.S., Gupta N., James C.D., Molinaro A., Phillips J.J. Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas. PLoS One 2012, 7:e43339.
37. Fan X., Mikolaenko I., Elhassan I., Ni X., Wang Y., Ball D., Brat D.J., Perry A., Eberhart C.G. Notch1 and notch2 have opposite effects on embryonal brain tumor growth. Cancer Res. 2004, 64:7787-7793.
38. Fernandez L.A., Northcott P.A., Taylor M.D., Kenney A.M. Normal and oncogenic roles for microRNAs in the developing brain. Cell Cycle 2009, 8:4049-4054.
39. Ferretti E., De Smaele E., Miele E., Laneve P., Po A., Pelloni M., Paganelli A., Di Marcotullio L., Caffarelli E., Screpanti I., Bozzoni I., Gulino A. Concerted microRNA control of Hedgehog signalling in cerebellar neuronal progenitor and tumour cells. EMBO J. 2008, 27:2616-2627.
40. Fineberg S.K., Kosik K.S., Davidson B.L. MicroRNAs potentiate neural development. Neuron 2009, 64:303-309.
41. Forsberg-Nilsson K., Behar T.N., Afrakhte M., Barker J.L., McKay R.D. Platelet-derived growth factor induces chemotaxis of neuroepithelial stem cells. J. Neurosci. Res. 1998, 53:521-530.
42. Friedmann-Morvinski D., Bushong E.A., Ke E., Soda Y., Marumoto T., Singer O., Ellisman M.H., Verma I.M. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science 2012, 338(6110):1080-1084.
43. Fuller G.N., Su X., Price R.E., Cohen Z.R., Lang F.F., Sawaya R., Majumder S. Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/neuron-restrictive silencer factor, which can be functionally countered by REST-VP16. Mol. Cancer Ther. 2005, 4:343-349.
44. Gangaraju V.K., Lin H. MicroRNAs: key regulators of stem cells. Nat. Rev. Mol. Cell Biol. 2009, 10:116-125.
45. Garzia L., Andolfo I., Cusanelli E., Marino N., Petrosino G., De Martino D., Esposito V., Galeone A., Navas L., Esposito S., Gargiulo S., Fattet S., Donofrio V., Cinalli G., Brunetti A., Vecchio L.D., Northcott P.A., Delattre O., Taylor M.D., Iolascon A., Zollo M. MicroRNA-199b-5p impairs cancer stem cells through negative regulation of HES1 in medulloblastoma. PLoS One 2009, 4:e4998.
46. Ghazi S.O., Stark M., Zhao Z., Mobley B.C., Munden A., Hover L., Abel T.W. Cell of origin determines tumor phenotype in an oncogenic Ras/p53 knockout transgenic model of high-grade glioma. J. Neuropathol. Exp. Neurol. 2012, 71:729-740.
47. Gibson P., Tong Y., Robinson G., Thompson M.C., Currle D.S., Eden C., Kranenburg T.A., Hogg T., Poppleton H., Martin J., Finkelstein D., Pounds S., Weiss A., Patay Z., Scoggins M., Ogg R., Pei Y., Yang Z.J., Brun S., Lee Y., Zindy F., Lindsey J.C., Taketo M.M., Boop F.A., Sanford R.A., Gajjar A., Clifford S.C., Roussel M.F., McKinnon P.J., Gutmann D.H., Ellison D.W., Wechsler-Reya R., Gilbertson R.J. Subtypes of medulloblastoma have distinct developmental origins. Nature 2010, 468:1095-1099.
48. Gil-Perotin S., Marin-Husstege M., Li J., Soriano-Navarro M., Zindy F., Roussel M.F., Garcia-Verdugo J.M., Casaccia-Bonnefil P. Loss of p53 induces changes in the behavior of subventricular zone cells: implication for the genesis of glial tumors. J. Neurosci. 2006, 26:1107-1116.
49. Gonzalez-Gomez P., Sanchez P., Mira H. MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme. Mol. Neurobiol. 2011, 44:235-249.
50. Gonzalez-Perez O., Romero-Rodriguez R., Soriano-Navarro M., Garcia-Verdugo J.M., Alvarez-Buylla A. Epidermal growth factor induces the progeny of subventricular zone type B cells to migrate and differentiate into oligodendrocytes. Stem Cells 2009, 27:2032-2043.
51. Goodrich L.V., Milenkovic L., Higgins K.M., Scott M.P. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science 1997, 277:1109-1113.
52. Gritti A., Frolichsthal-Schoeller P., Galli R., Parati E.A., Cova L., Pagano S.F., Bjornson C.R., Vescovi A.L. Epidermal and fibroblast growth factors behave as mitogenic regulators for a single multipotent stem cell-like population from the subventricular region of the adult mouse forebrain. J. Neurosci. 1999, 19:3287-3297.
53. Gronych J., Korshunov A., Bageritz J., Milde T., Jugold M., Hambardzumyan D., Remke M., Hartmann C., Witt H., Jones D.T., Witt O., Heiland S., Bendszus M., Holland E.C., Pfister S., Lichter P. An activated mutant BRAF kinase domain is sufficient to induce pilocytic astrocytoma in mice. J. Clin. Invest. 2011, 121:1344-1348.
54. Guessous F., Zhang Y., Kofman A., Catania A., Li Y., Schiff D., Purow B., Abounader R. microRNA-34a is tumor suppressive in brain tumors and glioma stem cells. Cell Cycle 2010, 9:1031-1036.
55. Guryanova O.A., Wu Q., Cheng L., Lathia J.D., Huang Z., Yang J., MacSwords J., Eyler C.E., McLendon R.E., Heddleston J.M., Shou W., Hambardzumyan D., Lee J., Hjelmeland A.B., Sloan A.E., Bredel M., Stark G.R., Rich J.N., Bao S. Nonreceptor tyrosine kinase BMX maintains self-renewal and tumorigenic potential of glioblastoma stem cells by activating STAT3. Cancer Cell 2011, 19:498-511.
56. Hall A., Giese N.A., Richardson W.D. Spinal cord oligodendrocytes develop from ventrally derived progenitor cells that express PDGF alpha-receptors. Development 1996, 122:4085-4094.
57. Hallahan A.R., Pritchard J.I., Hansen S., Benson M., Stoeck J., Hatton B.A., Russell T.L., Ellenbogen R.G., Bernstein I.D., Beachy P.A., Olson J.M. The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas. Cancer Res. 2004, 64:7794-7800.
58. Hansen D.V., Lui J.H., Parker P.R., Kriegstein A.R. Neurogenic radial glia in the outer subventricular zone of human neocortex. Nature 2010, 464:554-561.
59. Hatten M.E., Heintz N. Mechanisms of neural patterning and specification in the developing cerebellum. Annu. Rev. Neurosci. 1995, 18:385-408.
60. Hebert J.M., Fishell G. The genetics of early telencephalon patterning: some assembly required. Nat. Rev. Neurosci. 2008, 9:678-685.
61. Heddleston J.M., Li Z., McLendon R.E., Hjelmeland A.B., Rich J.N. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype. Cell Cycle 2009, 8:3274-3284.
62. Hemmati H.D., Nakano I., Lazareff J.A., Masterman-Smith M., Geschwind D.H., Bronner-Fraser M., Kornblum H.I. Cancerous stem cells can arise from pediatric brain tumors. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:15178-15183.
63. Hjelmeland A.B., Wu Q., Heddleston J.M., Choudhary G.S., MacSwords J., Lathia J.D., McLendon R., Lindner D., Sloan A., Rich J.N. Acidic stress promotes a glioma stem cell phenotype. Cell Death Differ. 2011, 18:829-840.
64. Hochstim C., Deneen B., Lukaszewicz A., Zhou Q., Anderson D.J. Identification of positionally distinct astrocyte subtypes whose identities are specified by a homeodomain code. Cell 2008, 133:510-522.
65. Hoffmeyer K., Raggioli A., Rudloff S., Anton R., Hierholzer A., Del Valle I., Hein K., Vogt R., Kemler R. Wnt/beta-catenin signaling regulates telomerase in stem cells and cancer cells. Science 2012, 336:1549-1554.
66. Hoshino M., Nakamura S., Mori K., Kawauchi T., Terao M., Nishimura Y.V., Fukuda A., Fuse T., Matsuo N., Sone M., Watanabe M., Bito H., Terashima T., Wright C.V., Kawaguchi Y., Nakao K., Nabeshima Y. Ptf1a, a bHLH transcriptional gene, defines GABAergic neuronal fates in cerebellum. Neuron 2005, 47:201-213.
67. Huse J.T., Holland E.C. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma. Nat. Rev. Cancer 2010, 10:319-331.
68. Ihrie R.A., Shah J.K., Harwell C.C., Levine J.H., Guinto C.D., Lezameta M., Kriegstein A.R., Alvarez-Buylla A. Persistent sonic hedgehog signaling in adult brain determines neural stem cell positional identity. Neuron 2011, 71:250-262.
69. Imai T., Tokunaga A., Yoshida T., Hashimoto M., Mikoshiba K., Weinmaster G., Nakafuku M., Okano H. The neural RNA-binding protein Musashi1 translationally regulates mammalian numb gene expression by interacting with its mRNA. Mol. Cell. Biol. 2001, 21:3888-3900.
70. Jackson E.L., Garcia-Verdugo J.M., Gil-Perotin S., Roy M., Quinones-Hinojosa A., VandenBerg S., Alvarez-Buylla A. PDGFR alpha-positive B cells are neural stem cells in the adult SVZ that form glioma-like growths in response to increased PDGF signaling. Neuron 2006, 51:187-199.
71. Jacques T.S., Swales A., Brzozowski M.J., Henriquez N.V., Linehan J.M., Mirzadeh Z., O'Malley C., Naumann H., Alvarez-Buylla A., Brandner S. Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes. EMBO J. 2010, 29:222-235.
72. Jain A.K., Allton K., Iacovino M., Mahen E., Milczarek R.J., Zwaka T.P., Kyba M., Barton M.C. p53 regulates cell cycle and microRNAs to promote differentiation of human embryonic stem cells. PLoS Biol. 2012, 10:e1001268.
73. Jeon H.M., Jin X., Lee J.S., Oh S.Y., Sohn Y.W., Park H.J., Joo K.M., Park W.Y., Nam D.H., DePinho R.A., Chin L., Kim H. Inhibitor of differentiation 4 drives brain tumor-initiating cell genesis through cyclin E and notch signaling. Genes Dev. 2008, 22:2028-2033.
74. Jeon H.M., Sohn Y.W., Oh S.Y., Kim S.H., Beck S., Kim S., Kim H. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2. Cancer Res. 2011, 71:3410-3421.
75. Johnson R.A., Wright K.D., Poppleton H., Mohankumar K.M., Finkelstein D., Pounds S.B., Rand V., Leary S.E., White E., Eden C., Hogg T., Northcott P., Mack S., Neale G., Wang Y.D., Coyle B., Atkinson J., DeWire M., Kranenburg T.A., Gillespie Y., Allen J.C., Merchant T., Boop F.A., Sanford R.A., Gajjar A., Ellison D.W., Taylor M.D., Grundy R.G., Gilbertson R.J. Cross-species genomics matches driver mutations and cell compartments to model ependymoma. Nature 2010, 466:632-636.
76. Jones D.T., Kocialkowski S., Liu L., Pearson D.M., Backlund L.M., Ichimura K., Collins V.P. Tandem duplication producing a novel oncogenic BRAF fusion gene defines the majority of pilocytic astrocytomas. Cancer Res. 2008, 68:8673-8677.
77. Jones D.T., Jager N., Kool M., Zichner T., Hutter B., Sultan M., Cho Y.J., Pugh T.J., Hovestadt V., Stutz A.M., Rausch T., Warnatz H.J., Ryzhova M., Bender S., Sturm D., Pleier S., Cin H., Pfaff E., Sieber L., Wittmann A., Remke M., Witt H., Hutter S., Tzaridis T., Weischenfeldt J., Raeder B., Avci M., Amstislavskiy V., Zapatka M., Weber U.D., Wang Q., Lasitschka B., Bartholomae C.C., Schmidt M., von Kalle C., Ast V., Lawerenz C., Eils J., Kabbe R., Benes V., van Sluis P., Koster J., Volckmann R., Shih D., Betts M.J., Russell R.B., Coco S., Tonini G.P., Schuller U., Hans V., Graf N., Kim Y.J., Monoranu C., Roggendorf W., Unterberg A., Herold-Mende C., Milde T., Kulozik A.E., von Deimling A., Witt O., Maass E., Rossler J., Ebinger M., Schuhmann M.U., Fruhwald M.C., Hasselblatt M., Jabado N., Rutkowski S., von Bueren A.O., Williamson D., Clifford S.C., McCabe M.G., Collins V.P., Wolf S., Wiemann S., Lehrach H., Brors B., Scheurlen W., Felsberg J., Reifenberger G., Northcott P.A., Taylor M.D., Meyerson M., Pomeroy S.L., Yaspo M.L., Korbel J.O., Korshunov A., Eils R., Pfister S.M., Lichter P. Dissecting the genomic complexity underlying medulloblastoma. Nature 2012, 488:100-105.
78. Kaneko Y., Sakakibara S., Imai T., Suzuki A., Nakamura Y., Sawamoto K., Ogawa Y., Toyama Y., Miyata T., Okano H. Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev. Neurosci. 2000, 22:139-153.
79. Katoh M. WNT signaling pathway and stem cell signaling network. Clin. Cancer Res. 2007, 13:4042-4045.
80. Kawauchi D., Robinson G., Uziel T., Gibson P., Rehg J., Gao C., Finkelstein D., Qu C., Pounds S., Ellison D.W., Gilbertson R.J., Roussel M.F. A mouse model of the most aggressive subgroup of human medulloblastoma. Cancer Cell 2012, 21:168-180.
81. Kilpatrick T.J., Bartlett P.F. Cloned multipotential precursors from the mouse cerebrum require FGF-2, whereas glial restricted precursors are stimulated with either FGF-2 or EGF. J. Neurosci. 1995, 15:3653-3661.
82. Kim J., Woo A.J., Chu J., Snow J.W., Fujiwara Y., Kim C.G., Cantor A.B., Orkin S.H. A Myc network accounts for similarities between embryonic stem and cancer cell transcription programs. Cell 2010, 143:313-324.
83. Kim Y., Kim E., Wu Q., Guryanova O., Hitomi M., Lathia J.D., Serwanski D., Sloan A.E., Weil R.J., Lee J., Nishiyama A., Bao S., Hjelmeland A.B., Rich J.N. Platelet-derived growth factor receptors differentially inform intertumoral and intratumoral heterogeneity. Genes Dev. 2012, 26:1247-1262.
84. Kioi M., Vogel H., Schultz G., Hoffman R.M., Harsh G.R., Brown J.M. Inhibition of vasculogenesis, but not angiogenesis, prevents the recurrence of glioblastoma after irradiation in mice. J. Clin. Invest. 2010, 120:694-705.
85. Knoepfler P.S. Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine. Stem Cells 2009, 27:1050-1056.
86. Knoepfler P.S., Cheng P.F., Eisenman R.N. N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 2002, 16:2699-2712.
87. Koirala S., Corfas G. Identification of novel glial genes by single-cell transcriptional profiling of Bergmann glial cells from mouse cerebellum. PLoS One 2010, 5:e9198.
88. Kool M., Koster J., Bunt J., Hasselt N.E., Lakeman A., van Sluis P., Troost D., Meeteren N.S., Caron H.N., Cloos J., Mrsic A., Ylstra B., Grajkowska W., Hartmann W., Pietsch T., Ellison D., Clifford S.C., Versteeg R. Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features. PLoS One 2008, 3:e3088.
89. Kuhn H.G., Winkler J., Kempermann G., Thal L.J., Gage F.H. Epidermal growth factor and fibroblast growth factor-2 have different effects on neural progenitors in the adult rat brain. J. Neurosci. 1997, 17:5820-5829.
90. Lai K., Kaspar B.K., Gage F.H., Schaffer D.V. Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat. Neurosci. 2003, 6:21-27.
91. Lai A., Kharbanda S., Pope W.B., Tran A., Solis O.E., Peale F., Forrest W.F., Pujara K., Carrillo J.A., Pandita A., Ellingson B.M., Bowers C.W., Soriano R.H., Schmidt N.O., Mohan S., Yong W.H., Seshagiri S., Modrusan Z., Jiang Z., Aldape K.D., Mischel P.S., Liau L.M., Escovedo C.J., Chen W., Nghiemphu P.L., James C.D., Prados M.D., Westphal M., Lamszus K., Cloughesy T., Phillips H.S. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. J. Clin. Oncol. 2011, 29:4482-4490.
92. Laks D.R., Masterman-Smith M., Visnyei K., Angenieux B., Orozco N.M., Foran I., Yong W.H., Vinters H.V., Liau L.M., Lazareff J.A., Mischel P.S., Cloughesy T.F., Horvath S., Kornblum H.I. Neurosphere formation is an independent predictor of clinical outcome in malignant glioma. Stem Cells 2009, 27:980-987.
93. Lamonica B.E., Lui J.H., Wang X., Kriegstein A.R. OSVZ progenitors in the human cortex: an updated perspective on neurodevelopmental disease. Curr. Opin. Neurobiol. 2012, 22(5):747-753.
94. Lee da Y., Gianino S.M., Gutmann D.H. Innate neural stem cell heterogeneity determines the patterning of glioma formation in children. Cancer Cell 2012, 22:131-138.
95. Lee J., Platt K.A., Censullo P., Ruiz i Altaba A. Gli1 is a target of Sonic hedgehog that induces ventral neural tube development. Development 1997, 124:2537-2552.
96. Li H., Collado M., Villasante A., Strati K., Ortega S., Canamero M., Blasco M.A., Serrano M. The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 2009, 460:1136-1139.
97. Li Y., Guessous F., Zhang Y., Dipierro C., Kefas B., Johnson E., Marcinkiewicz L., Jiang J., Yang Y., Schmittgen T.D., Lopes B., Schiff D., Purow B., Abounader R. MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes. Cancer Res. 2009, 69:7569-7576.
98. Li Z., Bao S., Wu Q., Wang H., Eyler C., Sathornsumetee S., Shi Q., Cao Y., Lathia J., McLendon R.E., Hjelmeland A.B., Rich J.N. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells. Cancer Cell 2009, 15:501-513.
99. Li Y., Li A., Glas M., Lal B., Ying M., Sang Y., Xia S., Trageser D., Guerrero-Cazares H., Eberhart C.G., Quinones-Hinojosa A., Scheffler B., Laterra J. c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:9951-9956.
100. Lie D.C., Colamarino S.A., Song H.J., Desire L., Mira H., Consiglio A., Lein E.S., Jessberger S., Lansford H., Dearie A.R., Gage F.H. Wnt signalling regulates adult hippocampal neurogenesis. Nature 2005, 437:1370-1375.
101. Lindberg N., Kastemar M., Olofsson T., Smits A., Uhrbom L. Oligodendrocyte progenitor cells can act as cell of origin for experimental glioma. Oncogene 2009, 28:2266-2275.
102. Listernick R., Darling C., Greenwald M., Strauss L., Charrow J. Optic pathway tumors in children: the effect of neurofibromatosis type 1 on clinical manifestations and natural history. J. Pediatr. 1995, 127:718-722.
103. Little S.E., Popov S., Jury A., Bax D.A., Doey L., Al-Sarraj S., Jurgensmeier J.M., Jones C. Receptor tyrosine kinase genes amplified in glioblastoma exhibit a mutual exclusivity in variable proportions reflective of individual tumor heterogeneity. Cancer Res. 2012, 72:1614-1620.
104. Liu H.K., Wang Y., Belz T., Bock D., Takacs A., Radlwimmer B., Barbus S., Reifenberger G., Lichter P., Schutz G. The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation. Genes Dev. 2010, 24:683-695.
105. Liu C., Sage J.C., Miller M.R., Verhaak R.G., Hippenmeyer S., Vogel H., Foreman O., Bronson R.T., Nishiyama A., Luo L., Zong H. Mosaic analysis with double markers reveals tumor cell of origin in glioma. Cell 2011, 146:209-221.
106. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., Scheithauer B.W., Kleihues P. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114:97-109.
107. Louvi A., Artavanis-Tsakonas S. Notch signalling in vertebrate neural development. Nat. Rev. Neurosci. 2006, 7:93-102.
108. Lu K.V., Chang J.P., Parachoniak C.A., Pandika M.M., Aghi M.K., Meyronet D., Isachenko N., Fouse S.D., Phillips J.J., Cheresh D.A., Park M., Bergers G. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex. Cancer Cell 2012, 22:21-35.
109. Mao J., Ligon K.L., Rakhlin E.Y., Thayer S.P., Bronson R.T., Rowitch D., McMahon A.P. A novel somatic mouse model to survey tumorigenic potential applied to the Hedgehog pathway. Cancer Res. 2006, 66:10171-10178.
110. Marion R.M., Strati K., Li H., Murga M., Blanco R., Ortega S., Fernandez-Capetillo O., Serrano M., Blasco M.A. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009, 460:1149-1153.
111. Marumoto T., Tashiro A., Friedmann-Morvinski D., Scadeng M., Soda Y., Gage F.H., Verma I.M. Development of a novel mouse glioma model using lentiviral vectors. Nat. Med. 2009, 15:110-116.
112. Mazzoleni S., Politi L.S., Pala M., Cominelli M., Franzin A., Sergi Sergi L., Falini A., De Palma M., Bulfone A., Poliani P.L., Galli R. Epidermal growth factor receptor expression identifies functionally and molecularly distinct tumor-initiating cells in human glioblastoma multiforme and is required for gliomagenesis. Cancer Res. 2010, 70:7500-7513.
113. Megason S.G., McMahon A.P. A mitogen gradient of dorsal midline Wnts organizes growth in the CNS. Development 2002, 129:2087-2098.
114. Merkle F.T., Tramontin A.D., Garcia-Verdugo J.M., Alvarez-Buylla A. Radial glia give rise to adult neural stem cells in the subventricular zone. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:17528-17532.
115. Merkle F.T., Mirzadeh Z., Alvarez-Buylla A. Mosaic organization of neural stem cells in the adult brain. Science 2007, 317:381-384.
116. Miale I.L., Sidman R.L. An autoradiographic analysis of histogenesis in the mouse cerebellum. Exp. Neurol. 1961, 4:277-296.
117. Mizutani K., Yoon K., Dang L., Tokunaga A., Gaiano N. Differential Notch signalling distinguishes neural stem cells from intermediate progenitors. Nature 2007, 449:351-355.
118. Momota H., Shih A.H., Edgar M.A., Holland E.C. c-Myc and beta-catenin cooperate with loss of p53 to generate multiple members of the primitive neuroectodermal tumor family in mice. Oncogene 2008, 27:4392-4401.
119. Monje M., Mitra S.S., Freret M.E., Raveh T.B., Kim J., Masek M., Attema J.L., Li G., Haddix T., Edwards M.S., Fisher P.G., Weissman I.L., Rowitch D.H., Vogel H., Wong A.J., Beachy P.A. Hedgehog-responsive candidate cell of origin for diffuse intrinsic pontine glioma. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:4453-4458.
120. Nishiyama A., Komitova M., Suzuki R., Zhu X. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat. Rev. Neurosci. 2009, 10:9-22.
121. Northcott P.A., Fernandez L.A., Hagan J.P., Ellison D.W., Grajkowska W., Gillespie Y., Grundy R., Van Meter T., Rutka J.T., Croce C.M., Kenney A.M., Taylor M.D. The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res. 2009, 69:3249-3255.
122. Northcott P.A., Nakahara Y., Wu X., Feuk L., Ellison D.W., Croul S., Mack S., Kongkham P.N., Peacock J., Dubuc A., Ra Y.S., Zilberberg K., McLeod J., Scherer S.W., Sunil Rao J., Eberhart C.G., Grajkowska W., Gillespie Y., Lach B., Grundy R., Pollack I.F., Hamilton R.L., Van Meter T., Carlotti C.G., Boop F., Bigner D., Gilbertson R.J., Rutka J.T., Taylor M.D. Multiple recurrent genetic events converge on control of histone lysine methylation in medulloblastoma. Nat. Genet. 2009, 41:465-472.
123. Northcott P.A., Korshunov A., Witt H., Hielscher T., Eberhart C.G., Mack S., Bouffet E., Clifford S.C., Hawkins C.E., French P., Rutka J.T., Pfister S., Taylor M.D. Medulloblastoma comprises four distinct molecular variants. J. Clin. Oncol. 2011, 29:1408-1414.
124. Northcott P.A., Shih D.J., Peacock J., Garzia L., Morrissy A.S., Zichner T., Stutz A.M., Korshunov A., Reimand J., Schumacher S.E., Beroukhim R., Ellison D.W., Marshall C.R., Lionel A.C., Mack S., Dubuc A., Yao Y., Ramaswamy V., Luu B., Rolider A., Cavalli F.M., Wang X., Remke M., Wu X., Chiu R.Y., Chu A., Chuah E., Corbett R.D., Hoad G.R., Jackman S.D., Li Y., Lo A., Mungall K.L., Nip K.M., Qian J.Q., Raymond A.G., Thiessen N.T., Varhol R.J., Birol I., Moore R.A., Mungall A.J., Holt R., Kawauchi D., Roussel M.F., Kool M., Jones D.T., Witt H., Fernandez L.A., Kenney A.M., Wechsler-Reya R.J., Dirks P., Aviv T., Grajkowska W.A., Perek-Polnik M., Haberler C.C., Delattre O., Reynaud S.S., Doz F.F., Pernet-Fattet S.S., Cho B.K., Kim S.K., Wang K.C., Scheurlen W., Eberhart C.G., Fevre-Montange M., Jouvet A., Pollack I.F., Fan X., Muraszko K.M., Gillespie G.Y., Di Rocco C., Massimi L., Michiels E.M., Kloosterhof N.K., French P.J., Kros J.M., Olson J.M., Ellenbogen R.G., Zitterbart K., Kren L., Thompson R.C., Cooper M.K., Lach B., McLendon R.E., Bigner D.D., Fontebasso A., Albrecht S., Jabado N., Lindsey J.C., Bailey S., Gupta N., Weiss W.A., Bognar L., Klekner A., Van Meter T.E., Kumabe T., Tominaga T., Elbabaa S.K., Leonard J.R., Rubin J.B., et al. Subgroup-specific structural variation across 1,000 medulloblastoma genomes. Nature 2012, 488:49-56.
125. Northcott P.A., Shih D.J., Remke M., Cho Y.J., Kool M., Hawkins C., Eberhart C.G., Dubuc A., Guettouche T., Cardentey Y., Bouffet E., Pomeroy S.L., Marra M., Malkin D., Rutka J.T., Korshunov A., Pfister S., Taylor M.D. Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples. Acta Neuropathol. 2012, 123:615-626.
126. Noushmehr H., Weisenberger D.J., Diefes K., Phillips H.S., Pujara K., Berman B.P., Pan F., Pelloski C.E., Sulman E.P., Bhat K.P., Verhaak R.G., Hoadley K.A., Hayes D.N., Perou C.M., Schmidt H.K., Ding L., Wilson R.K., Van Den Berg D., Shen H., Bengtsson H., Neuvial P., Cope L.M., Buckley J., Herman J.G., Baylin S.B., Laird P.W., Aldape K. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 2010, 17:510-522.
127. Okita K., Ichisaka T., Yamanaka S. Generation of germline-competent induced pluripotent stem cells. Nature 2007, 448:313-317.
128. Pacal M., Bremner R. Insights from animal models on the origins and progression of retinoblastoma. Curr. Mol. Med. 2006, 6:759-781.
129. Palma V., Ruiz i Altaba A. Hedgehog-GLI signaling regulates the behavior of cells with stem cell properties in the developing neocortex. Development 2004, 131:337-345.
130. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A., Lerou P.H., Lensch M.W., Daley G.Q. Reprogramming of human somatic cells to pluripotency with defined factors. Nature 2008, 451:141-146.
131. Parsons D.W., Jones S., Zhang X., Lin J.C., Leary R.J., Angenendt P., Mankoo P., Carter H., Siu I.M., Gallia G.L., Olivi A., McLendon R., Rasheed B.A., Keir S., Nikolskaya T., Nikolsky Y., Busam D.A., Tekleab H., Diaz L.A., Hartigan J., Smith D.R., Strausberg R.L., Marie S.K., Shinjo S.M., Yan H., Riggins G.J., Bigner D.D., Karchin R., Papadopoulos N., Parmigiani G., Vogelstein B., Velculescu V.E., Kinzler K.W. An integrated genomic analysis of human glioblastoma multiforme. Science 2008, 321:1807-1812.
132. Parsons D.W., Li M., Zhang X., Jones S., Leary R.J., Lin J.C., Boca S.M., Carter H., Samayoa J., Bettegowda C., Gallia G.L., Jallo G.I., Binder Z.A., Nikolsky Y., Hartigan J., Smith D.R., Gerhard D.S., Fults D.W., VandenBerg S., Berger M.S., Marie S.K., Shinjo S.M., Clara C., Phillips P.C., Minturn J.E., Biegel J.A., Judkins A.R., Resnick A.C., Storm P.B., Curran T., He Y., Rasheed B.A., Friedman H.S., Keir S.T., McLendon R., Northcott P.A., Taylor M.D., Burger P.C., Riggins G.J., Karchin R., Parmigiani G., Bigner D.D., Yan H., Papadopoulos N., Vogelstein B., Kinzler K.W., Velculescu V.E. The genetic landscape of the childhood cancer medulloblastoma. Science 2011, 331:435-439.
133. Pei Y., Brun S.N., Markant S.L., Lento W., Gibson P., Taketo M.M., Giovannini M., Gilbertson R.J., Wechsler-Reya R.J. WNT signaling increases proliferation and impairs differentiation of stem cells in the developing cerebellum. Development 2012, 139:1724-1733.
134. Pei Y., Moore C.E., Wang J., Tewari A.K., Eroshkin A., Cho Y.J., Witt H., Korshunov A., Read T.A., Sun J.L., Schmitt E.M., Miller C.R., Buckley A.F., McLendon R.E., Westbrook T.F., Northcott P.A., Taylor M.D., Pfister S.M., Febbo P.G., Wechsler-Reya R.J. An animal model of MYC-driven medulloblastoma. Cancer Cell 2012, 21:155-167.
135. Persson A.I., Petritsch C., Swartling F.J., Itsara M., Sim F.J., Auvergne R., Goldenberg D.D., Vandenberg S.R., Nguyen K.N., Yakovenko S., Ayers-Ringler J., Nishiyama A., Stallcup W.B., Berger M.S., Bergers G., McKnight T.R., Goldman S.A., Weiss W.A. Non-stem cell origin for oligodendroglioma. Cancer Cell 2010, 18:669-682.
136. Pfister S., Janzarik W.G., Remke M., Ernst A., Werft W., Becker N., Toedt G., Wittmann A., Kratz C., Olbrich H., Ahmadi R., Thieme B., Joos S., Radlwimmer B., Kulozik A., Pietsch T., Herold-Mende C., Gnekow A., Reifenberger G., Korshunov A., Scheurlen W., Omran H., Lichter P. BRAF gene duplication constitutes a mechanism of MAPK pathway activation in low-grade astrocytomas. J. Clin. Invest. 2008, 118:1739-1749.
137. Pfister S., Remke M., Benner A., Mendrzyk F., Toedt G., Felsberg J., Wittmann A., Devens F., Gerber N.U., Joos S., Kulozik A., Reifenberger G., Rutkowski S., Wiestler O.D., Radlwimmer B., Scheurlen W., Lichter P., Korshunov A. Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci. J. Clin. Oncol. 2009, 27:1627-1636.
138. Phillips H.S., Kharbanda S., Chen R., Forrest W.F., Soriano R.H., Wu T.D., Misra A., Nigro J.M., Colman H., Soroceanu L., Williams P.M., Modrusan Z., Feuerstein B.G., Aldape K. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. Cancer Cell 2006, 9:157-173.
139. Pistollato F., Abbadi S., Rampazzo E., Persano L., Della Puppa A., Frasson C., Sarto E., Scienza R., D'Avella D., Basso G. Intratumoral hypoxic gradient drives stem cells distribution and MGMT expression in glioblastoma. Stem Cells 2010, 28:851-862.
140. Po A., Ferretti E., Miele E., De Smaele E., Paganelli A., Canettieri G., Coni S., Di Marcotullio L., Biffoni M., Massimi L., Di Rocco C., Screpanti I., Gulino A. Hedgehog controls neural stem cells through p53-independent regulation of Nanog. EMBO J. 2010, 29:2646-2658.
141. Polajeva J., Swartling F.J., Jiang Y., Singh U., Pietras K., Uhrbom L., Westermark B., Roswall P. miRNA-21 is developmentally regulated in mouse brain and is co-expressed with SOX2 in glioma. BMC Cancer 2012, 12:378.
142. Pugh T.J., Weeraratne S.D., Archer T.C., Pomeranz Krummel D.A., Auclair D., Bochicchio J., Carneiro M.O., Carter S.L., Cibulskis K., Erlich R.L., Greulich H., Lawrence M.S., Lennon N.J., McKenna A., Meldrim J., Ramos A.H., Ross M.G., Russ C., Shefler E., Sivachenko A., Sogoloff B., Stojanov P., Tamayo P., Mesirov J.P., Amani V., Teider N., Sengupta S., Francois J.P., Northcott P.A., Taylor M.D., Yu F., Crabtree G.R., Kautzman A.G., Gabriel S.B., Getz G., Jager N., Jones D.T., Lichter P., Pfister S.M., Roberts T.M., Meyerson M., Pomeroy S.L., Cho Y.J. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 2012, 488:106-110.
143. Qu J., Bishop J.M. Nucleostemin maintains self-renewal of embryonic stem cells and promotes reprogramming of somatic cells to pluripotency. J. Cell Biol. 2012, 197:731-745.
144. Rakic P. Principles of neural cell migration. Experientia 1990, 46:882-891.
145. Rangarajan A., Weinberg R.A. Opinion: comparative biology of mouse versus human cells: modelling human cancer in mice. Nat. Rev. Cancer 2003, 3:952-959.
146. Rangarajan A., Hong S.J., Gifford A., Weinberg R.A. Species- and cell type-specific requirements for cellular transformation. Cancer Cell 2004, 6:171-183.
147. Rao G., Pedone C.A., Coffin C.M., Holland E.C., Fults D.W. c-Myc enhances sonic hedgehog-induced medulloblastoma formation from nestin-expressing neural progenitors in mice. Neoplasia 2003, 5:198-204.
148. Reilly K.M., Loisel D.A., Bronson R.T., McLaughlin M.E., Jacks T. Nf1; Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects. Nat. Genet. 2000, 26:109-113.
149. Robinson G., Parker M., Kranenburg T.A., Lu C., Chen X., Ding L., Phoenix T.N., Hedlund E., Wei L., Zhu X., Chalhoub N., Baker S.J., Huether R., Kriwacki R., Curley N., Thiruvenkatam R., Wang J., Wu G., Rusch M., Hong X., Becksfort J., Gupta P., Ma J., Easton J., Vadodaria B., Onar-Thomas A., Lin T., Li S., Pounds S., Paugh S., Zhao D., Kawauchi D., Roussel M.F., Finkelstein D., Ellison D.W., Lau C.C., Bouffet E., Hassall T., Gururangan S., Cohn R., Fulton R.S., Fulton L.L., Dooling D.J., Ochoa K., Gajjar A., Mardis E.R., Wilson R.K., Downing J.R., Zhang J., Gilbertson R.J. Novel mutations target distinct subgroups of medulloblastoma. Nature 2012, 488:43-48.
150. Ryan S.L., Schwalbe E.C., Cole M., Lu Y., Lusher M.E., Megahed H., O'Toole K., Nicholson S.L., Bognar L., Garami M., Hauser P., Korshunov A., Pfister S.M., Williamson D., Taylor R.E., Ellison D.W., Bailey S., Clifford S.C. MYC family amplification and clinical risk-factors interact to predict an extremely poor prognosis in childhood medulloblastoma. Acta Neuropathol. 2012, 123:501-513.
151. Sanai N., Nguyen T., Ihrie R.A., Mirzadeh Z., Tsai H.H., Wong M., Gupta N., Berger M.S., Huang E., Garcia-Verdugo J.M., Rowitch D.H., Alvarez-Buylla A. Corridors of migrating neurons in the human brain and their decline during infancy. Nature 2011, 478:382-386.
152. Sanalkumar R., Dhanesh S.B., James J. Non-canonical activation of Notch signaling/target genes in vertebrates. Cell. Mol. Life Sci. 2010, 67:2957-2968.
153. Schuller U., Heine V.M., Mao J., Kho A.T., Dillon A.K., Han Y.G., Huillard E., Sun T., Ligon A.H., Qian Y., Ma Q., Alvarez-Buylla A., McMahon A.P., Rowitch D.H., Ligon K.L. Acquisition of granule neuron precursor identity is a critical determinant of progenitor cell competence to form Shh-induced medulloblastoma. Cancer Cell 2008, 14:123-134.
154. Schwartzentruber J., Korshunov A., Liu X.Y., Jones D.T., Pfaff E., Jacob K., Sturm D., Fontebasso A.M., Quang D.A., Tonjes M., Hovestadt V., Albrecht S., Kool M., Nantel A., Konermann C., Lindroth A., Jager N., Rausch T., Ryzhova M., Korbel J.O., Hielscher T., Hauser P., Garami M., Klekner A., Bognar L., Ebinger M., Schuhmann M.U., Scheurlen W., Pekrun A., Fruhwald M.C., Roggendorf W., Kramm C., Durken M., Atkinson J., Lepage P., Montpetit A., Zakrzewska M., Zakrzewski K., Liberski P.P., Dong Z., Siegel P., Kulozik A.E., Zapatka M., Guha A., Malkin D., Felsberg J., Reifenberger G., von Deimling A., Ichimura K., Collins V.P., Witt H., Milde T., Witt O., Zhang C., Castelo-Branco P., Lichter P., Faury D., Tabori U., Plass C., Majewski J., Pfister S.M., Jabado N. Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma. Nature 2012, 482:226-231.
155. Scott C.E., Wynn S.L., Sesay A., Cruz C., Cheung M., Gomez Gaviro M.V., Booth S., Gao B., Cheah K.S., Lovell-Badge R., Briscoe J. SOX9 induces and maintains neural stem cells. Nat. Neurosci. 2010, 13:1181-1189.
156. Sharma M.K., Mansur D.B., Reifenberger G., Perry A., Leonard J.R., Aldape K.D., Albin M.G., Emnett R.J., Loeser S., Watson M.A., Nagarajan R., Gutmann D.H. Distinct genetic signatures among pilocytic astrocytomas relate to their brain region origin. Cancer Res. 2007, 67:890-900.
157. Shih C.C., Forman S.J., Chu P., Slovak M. Human embryonic stem cells are prone to generate primitive, undifferentiated tumors in engrafted human fetal tissues in severe combined immunodeficient mice. Stem Cells Dev. 2007, 16:893-902.
158. Shimozaki K., Zhang C.L., Suh H., Denli A.M., Evans R.M., Gage F.H. SRY-box-containing gene 2 regulation of nuclear receptor tailless (Tlx) transcription in adult neural stem cells. J. Biol. Chem. 2012, 287:5969-5978.
159. Shook B.A., Manz D.H., Peters J.J., Kang S., Conover J.C. Spatiotemporal changes to the subventricular zone stem cell pool through aging. J. Neurosci. 2012, 32:6947-6956.
160. Silber J., Lim D.A., Petritsch C., Persson A.I., Maunakea A.K., Yu M., Vandenberg S.R., Ginzinger D.G., James C.D., Costello J.F., Bergers G., Weiss W.A., Alvarez-Buylla A., Hodgson J.G. miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells. BMC Med. 2008, 6:14.
161. Sim F.J., Windrem M.S., Goldman S.A. Fate determination of adult human glial progenitor cells. Neuron Glia Biol. 2009, 5:45-55.
162. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., Dirks P.B. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003, 63:5821-5828.
163. Singh S.K., Kagalwala M.N., Parker-Thornburg J., Adams H., Majumder S. REST maintains self-renewal and pluripotency of embryonic stem cells. Nature 2008, 453:223-227.
164. Snuderl M., Fazlollahi L., Le L.P., Nitta M., Zhelyazkova B.H., Davidson C.J., Akhavanfard S., Cahill D.P., Aldape K.D., Betensky R.A., Louis D.N., Iafrate A.J. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma. Cancer Cell 2011, 20:810-817.
165. Soldati C., Bithell A., Johnston C., Wong K.Y., Teng S.W., Beglopoulos V., Stanton L.W., Buckley N.J. Repressor element 1 silencing transcription factor couples loss of pluripotency with neural induction and neural differentiation. Stem Cells 2012, 30:425-434.
166. Solecki D.J., Liu X.L., Tomoda T., Fang Y., Hatten M.E. Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation. Neuron 2001, 31:557-568.
167. Sottile V., Li M., Scotting P.J. Stem cell marker expression in the Bergmann glia population of the adult mouse brain. Brain Res. 2006, 1099:8-17.
168. Sturm D., Witt H., Hovestadt V., Khuong-Quang D.A., Jones D.T., Konermann C., Pfaff E., Tonjes M., Sill M., Bender S., Kool M., Zapatka M., Becker N., Zucknick M., Hielscher T., Liu X.Y., Fontebasso A.M., Ryzhova M., Albrecht S., Jacob K., Wolter M., Ebinger M., Schuhmann M.U., van Meter T., Fruhwald M.C., Hauch H., Pekrun A., Radlwimmer B., Niehues T., von Komorowski G., Durken M., Kulozik A.E., Madden J., Donson A., Foreman N.K., Drissi R., Fouladi M., Scheurlen W., von Deimling A., Monoranu C., Roggendorf W., Herold-Mende C., Unterberg A., Kramm C.M., Felsberg J., Hartmann C., Wiestler B., Wick W., Milde T., Witt O., Lindroth A.M., Schwartzentruber J., Faury D., Fleming A., Zakrzewska M., Liberski P.P., Zakrzewski K., Hauser P., Garami M., Klekner A., Bognar L., Morrissy S., Cavalli F., Taylor M.D., van Sluis P., Koster J., Versteeg R., Volckmann R., Mikkelsen T., Aldape K., Reifenberger G., Collins V.P., Majewski J., Korshunov A., Lichter P., Plass C., Jabado N., Pfister S.M. Hotspot mutations in H3F3A and IDH1 define distinct epigenetic and biological subgroups of glioblastoma. Cancer Cell 2012, 22:425-437.
169. Su X., Gopalakrishnan V., Stearns D., Aldape K., Lang F.F., Fuller G., Snyder E., Eberhart C.G., Majumder S. Abnormal expression of REST/NRSF and Myc in neural stem/progenitor cells causes cerebellar tumors by blocking neuronal differentiation. Mol. Cell. Biol. 2006, 26:1666-1678.
170. Suva M.L., Riggi N., Janiszewska M., Radovanovic I., Provero P., Stehle J.C., Baumer K., Le Bitoux M.A., Marino D., Cironi L., Marquez V.E., Clement V., Stamenkovic I. EZH2 is essential for glioblastoma cancer stem cell maintenance. Cancer Res. 2009, 69:9211-9218.
171. Swartling F.J. Myc proteins in brain tumor development and maintenance. Ups. J. Med. Sci. 2012, 117:122-131.
172. Swartling F.J., Grimmer M.R., Hackett C.S., Northcott P.A., Fan Q.W., Goldenberg D.D., Lau J., Masic S., Nguyen K., Yakovenko S., Zhe X.N., Gilmer H.C., Collins R., Nagaoka M., Phillips J.J., Jenkins R.B., Tihan T., Vandenberg S.R., James C.D., Tanaka K., Taylor M.D., Weiss W.A., Chesler L. Pleiotropic role for MYCN in medulloblastoma. Genes Dev. 2010, 24:1059-1072.
173. Swartling F.J., Savov V., Persson A.I., Chen J., Hackett C.S., Northcott P.A., Grimmer M.R., Lau J., Chesler L., Perry A., Phillips J.J., Taylor M.D., Weiss W.A. Distinct neural stem cell populations give rise to disparate brain tumors in response to N-MYC. Cancer Cell 2012, 21:601-613.
174. Szerlip N.J., Pedraza A., Chakravarty D., Azim M., McGuire J., Fang Y., Ozawa T., Holland E.C., Huse J.T., Jhanwar S., Leversha M.A., Mikkelsen T., Brennan C.W. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:3041-3046.
175. Takahashi K., Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 2006, 126:663-676.
176. Takwi A.A., Li Y., Becker Buscaglia L.E., Zhang J., Choudhury S., Park A.K., Liu M., Young K.H., Park W.Y., Martin R.C. A statin-regulated microRNA represses human c-Myc expression and function. EMBO Mol. Med. 2012, 4:896-909.
177. Taylor M.D., Poppleton H., Fuller C., Su X., Liu Y., Jensen P., Magdaleno S., Dalton J., Calabrese C., Board J., Macdonald T., Rutka J., Guha A., Gajjar A., Curran T., Gilbertson R.J. Radial glia cells are candidate stem cells of ependymoma. Cancer Cell 2005, 8:323-335.
178. Taylor M.D., Northcott P.A., Korshunov A., Remke M., Cho Y.J., Clifford S.C., Eberhart C.G., Parsons D.W., Rutkowski S., Gajjar A., Ellison D.W., Lichter P., Gilbertson R.J., Pomeroy S.L., Kool M., Pfister S.M. Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol. 2012, 123:465-472.
179. Taylor P., Fangusaro J., Rajaram V., Goldman S., Helenowski I.B., Macdonald T., Hasselblatt M., Riedemann L., Laureano A., Cooper L., Gopalakrishnan V. REST is a novel prognostic factor and therapeutic target for medulloblastoma. Mol. Cancer Ther. 2012, 11:1713-1723.
180. ten Berge D., Kurek D., Blauwkamp T., Koole W., Maas A., Eroglu E., Siu R.K., Nusse R. Embryonic stem cells require Wnt proteins to prevent differentiation to epiblast stem cells. Nat. Cell Biol. 2011, 13:1070-1075.
181. Thompson M.C., Fuller C., Hogg T.L., Dalton J., Finkelstein D., Lau C.C., Chintagumpala M., Adesina A., Ashley D.M., Kellie S.J., Taylor M.D., Curran T., Gajjar A., Gilbertson R.J. Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations. J. Clin. Oncol. 2006, 24:1924-1931.
182. Tropepe V., Sibilia M., Ciruna B.G., Rossant J., Wagner E.F., van der Kooy D. Distinct neural stem cells proliferate in response to EGF and FGF in the developing mouse telencephalon. Dev. Biol. 1999, 208:166-188.
183. Turcan S., Rohle D., Goenka A., Walsh L.A., Fang F., Yilmaz E., Campos C., Fabius A.W., Lu C., Ward P.S., Thompson C.B., Kaufman A., Guryanova O., Levine R., Heguy A., Viale A., Morris L.G., Huse J.T., Mellinghoff I.K., Chan T.A. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature 2012, 483:479-483.
184. Uziel T., Karginov F.V., Xie S., Parker J.S., Wang Y.D., Gajjar A., He L., Ellison D., Gilbertson R.J., Hannon G., Roussel M.F. The miR-17 92 cluster collaborates with the sonic hedgehog pathway in medulloblastoma. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:2812-2817.
185. Valk-Lingbeek M.E., Bruggeman S.W., van Lohuizen M. Stem cells and cancer; the polycomb connection. Cell 2004, 118:409-418.
186. Vaupel P., Kallinowski F., Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res. 1989, 49:6449-6465.
187. Verhaak R.G., Hoadley K.A., Purdom E., Wang V., Qi Y., Wilkerson M.D., Miller C.R., Ding L., Golub T., Mesirov J.P., Alexe G., Lawrence M., O'Kelly M., Tamayo P., Weir B.A., Gabriel S., Winckler W., Gupta S., Jakkula L., Feiler H.S., Hodgson J.G., James C.D., Sarkaria J.N., Brennan C., Kahn A., Spellman P.T., Wilson R.K., Speed T.P., Gray J.W., Meyerson M., Getz G., Perou C.M., Hayes D.N. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 2010, 17:98-110.
188. Wang Y., Yang J., Zheng H., Tomasek G.J., Zhang P., McKeever P.E., Lee E.Y., Zhu Y. Expression of mutant p53 proteins implicates a lineage relationship between neural stem cells and malignant astrocytic glioma in a murine model. Cancer Cell 2009, 15:514-526.
189. Wang X., Venugopal C., Manoranjan B., McFarlane N., O'Farrell E., Nolte S., Gunnarsson T., Hollenberg R., Kwiecien J., Northcott P., Taylor M.D., Hawkins C., Singh S.K. Sonic hedgehog regulates Bmi1 in human medulloblastoma brain tumor-initiating cells. Oncogene 2012, 31:187-199.
190. Wechsler-Reya R.J., Scott M.P. Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog. Neuron 1999, 22:103-114.
191. Weeraratne S.D., Amani V., Neiss A., Teider N., Scott D.K., Pomeroy S.L., Cho Y.J. miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma. Neuro Oncol. 2011, 13:165-175.
192. Weiner H.L., Bakst R., Hurlbert M.S., Ruggiero J., Ahn E., Lee W.S., Stephen D., Zagzag D., Joyner A.L., Turnbull D.H. Induction of medulloblastomas in mice by sonic hedgehog, independent of Gli1. Cancer Res. 2002, 62:6385-6389.
193. Weiss S., Dunne C., Hewson J., Wohl C., Wheatley M., Peterson A.C., Reynolds B.A. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J. Neurosci. 1996, 16:7599-7609.
194. Weiss W.A., Burns M.J., Hackett C., Aldape K., Hill J.R., Kuriyama H., Kuriyama N., Milshteyn N., Roberts T., Wendland M.F., DePinho R., Israel M.A. Genetic determinants of malignancy in a mouse model for oligodendroglioma. Cancer Res. 2003, 63:1589-1595.
195. Wey A., Martinez Cerdeno V., Pleasure D., Knoepfler P.S. c- and N-myc regulate neural precursor cell fate, cell cycle, and metabolism to direct cerebellar development. Cerebellum 2010, 9:537-547.
196. Widschwendter M., Fiegl H., Egle D., Mueller-Holzner E., Spizzo G., Marth C., Weisenberger D.J., Campan M., Young J., Jacobs I., Laird P.W. Epigenetic stem cell signature in cancer. Nat. Genet. 2007, 39:157-158.
197. Wu A., Wei J., Kong L.Y., Wang Y., Priebe W., Qiao W., Sawaya R., Heimberger A.B. Glioma cancer stem cells induce immunosuppressive macrophages/microglia. Neuro Oncol. 2010, 12:1113-1125.
198. Wu G., Broniscer A., McEachron T.A., Lu C., Paugh B.S., Becksfort J., Qu C., Ding L., Huether R., Parker M., Zhang J., Gajjar A., Dyer M.A., Mullighan C.G., Gilbertson R.J., Mardis E.R., Wilson R.K., Downing J.R., Ellison D.W., Baker S.J. Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas. Nat. Genet. 2012, 44:251-253.
199. Xu Y., Tamamaki N., Noda T., Kimura K., Itokazu Y., Matsumoto N., Dezawa M., Ide C. Neurogenesis in the ependymal layer of the adult rat 3rd ventricle. Exp. Neurol. 2005, 192:251-264.
200. Yang Z.J., Ellis T., Markant S.L., Read T.A., Kessler J.D., Bourboulas M., Schuller U., Machold R., Fishell G., Rowitch D.H., Wainwright B.J., Wechsler-Reya R.J. Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells. Cancer Cell 2008, 14:135-145.
201. Yoon K., Gaiano N. Notch signaling in the mammalian central nervous system: insights from mouse mutants. Nat. Neurosci. 2005, 8:709-715.
202. Zbinden M., Duquet A., Lorente-Trigos A., Ngwabyt S.N., Borges I., Ruiz i Altaba A. NANOG regulates glioma stem cells and is essential in vivo acting in a cross-functional network with GLI1 and p53. EMBO J. 2010, 29:2659-2674.
203. Zhao C., Sun G., Li S., Shi Y. A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat. Struct. Mol. Biol. 2009, 16:365-371.
204. Zheng H., Ying H., Yan H., Kimmelman A.C., Hiller D.J., Chen A.J., Perry S.R., Tonon G., Chu G.C., Ding Z., Stommel J.M., Dunn K.L., Wiedemeyer R., You M.J., Brennan C., Wang Y.A., Ligon K.L., Wong W.H., Chin L., DePinho R.A. p53 and Pten control neural and glioma stem/progenitor cell renewal and differentiation. Nature 2008, 455:1129-1133.
205. Zhu Y., Guignard F., Zhao D., Liu L., Burns D.K., Mason R.P., Messing A., Parada L.F. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. Cancer Cell 2005, 8:119-130.